GBT

Oncology

The systems needed to deliver GBT testing consistently across the NHS are still evolving to keep pace with these scientific advances.

News

Mission Therapeutics has struck a deal to out-license a drug for acute kidney injury to Australia's Dimerix, sharpening its focus on CNS diseases.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.